Resources

Glossary

Medical Terms and Diagnostic Markers

Ab Antibody
Ag Antigen
ALT Alanine aminotransferase
APRI AST to platelet ratio index
AST Aspartate aminotransferase
BMI Body mass index
CC Compensated cirrhosis
CKD Chronic kidney disease
CrCl Creatinine clearance
CTP Child-Turcotte-Pugh
DAA Direct-acting antiviral
DBS Dried blood spot
ESLD End-stage liver disease
FIB-4 Fibrosis-4
GFR Glomerular filtration rate
GT Genotype
HBV Hepatitis B virus
HCC Hepatocellular carcinoma
HCV Hepatitis C virus
INF Interferon
LSM Liver stiffness measure
MELD Model for End-Stage Liver Disease
PCR Polymerase chain reaction
RNA Ribonucleic acid
SVR12 Sustained virologic response 12 weeks post-treatment

Healthcare and Treatment Organizations

AASLD American Association for the Study of Liver Diseases
ASAM American Society of Addiction Medicine
CDC Centers for Disease Control and Prevention
EASL European Association for the Study of the Liver
FDA Food and Drug Administration
HCP Healthcare professional
HHS Health and Human Services
IDSA Infectious Diseases Society of America
MSL Medical science liaison
NP Nurse practitioner
NASEN North America Syringe Exchange Network
NASTAD Community Navigation Model and Toolkit
SAMHSA Substance Abuse and Mental Health Services Administration
USPSTF US Preventive Services Task Force
WHO World Health Organization

Substance Use, Risk, and Testing Programs

AUDIT-C Alcohol Use Disorders Identification Test
BBV Blood borne viruses
DDI Drug-drug interaction
IDU Injecting drug use
LTF Lost to follow-up
MSM Men who have sex with men
NSP Needle-syringe programs
OAT Opioid agonist therapy
ORT Opioid Risk Tool
OST Opioid substitution therapy
OUD Opioid use disorder
PNSP Prison needle and syringe programs
PoCT Point of care testing
PREP-C Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
PWID People who inject drugs
PWUD People who use drugs
SEP Syringe exchange programs
SoC Standard of care
STBBI Sexually transmitted blood borne infections
SUD Substance use disorder